tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks management to meet with B. Riley
The FlyZymeworks management to meet with B. Riley
13h ago
ZYME
Zymeworks price target raised to $31 from $28 at Truist
PremiumThe Fly
Zymeworks price target raised to $31 from $28 at Truist
15d ago
ZYME
Zymeworks price target raised to $37 from $34 at Wells Fargo
PremiumThe Fly
Zymeworks price target raised to $37 from $34 at Wells Fargo
22d ago
ZYME
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
PremiumRatings
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
22d ago
ZYME
Zymeworks price target raised to $37 from $35 at Citi
PremiumThe Fly
Zymeworks price target raised to $37 from $35 at Citi
22d ago
TBPH
ZYME
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
PremiumRatingsZymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
23d ago
ZYME
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
Premium
The Fly
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
23d ago
VZ
BTI
Zymeworks to Acquire Theravance in Strategic Merger
Premium
Company Announcements
Zymeworks to Acquire Theravance in Strategic Merger
23d ago
8K
ZYME
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
PremiumMarket News
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
23d ago
TBPH
ZYME
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
PremiumThe Fly
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
23d ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
PremiumThe Fly
Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
23d ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share
PremiumThe Fly
Zymeworks to acquire Theravance Biopharma for $17.00 per share
23d ago
TBPH
ZYME
Zymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
PremiumRatingsZymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
23d ago
ZYME
Context Therapeutics selloff brings buying opportunity, says JonesResearch
Premium
The Fly
Context Therapeutics selloff brings buying opportunity, says JonesResearch
1M ago
CNTX
ZYME
Zymeworks presents new clinical data on Phase 1 study of ZW191
Premium
The Fly
Zymeworks presents new clinical data on Phase 1 study of ZW191
1M ago
ZYME
Zymeworks assumed with a Buy at Truist
PremiumThe Fly
Zymeworks assumed with a Buy at Truist
1M ago
ZYME
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
PremiumCompany Announcements
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
2M ago
ONC
ZYME
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
PremiumRatings
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
2M ago
ZYME
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
2M ago
AZN
LLY
Zymeworks Earnings Call Balances Promise and Risk
PremiumCompany AnnouncementsZymeworks Earnings Call Balances Promise and Risk
2M ago
ZYME
Zymeworks authorizes share repurchase program of up to $125M
Premium
The Fly
Zymeworks authorizes share repurchase program of up to $125M
2M ago
ZYME
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
Premium
Company Announcements
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
2M ago
8K
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >